knowledge -WSS

knowledge

author：knowledge 2025-09-02 17:42:42 - browse：5211

On Tuesday, Google DeepMind and Isomorphic Labs announced a significant progress update on the next iteration of AlphaFold, the deep learning model that in 2020 cracked the problem of predicting a protein’s structure from its amino acid sequence, leapfrogging other approaches in computational biology.

Now, the companies say they have developed the model to predict not just standalone protein structures, but what proteins look like in combination with several classes of molecules, including small molecules and nucleic acids — capabilities that are key for drug development.

“We really needed to make progress on protein-ligand binding and co-folding of ligands with proteins in order to help us design more effective drugs,” said Demis Hassabis, CEO of both DeepMind and Isomorphic Labs, which spun out in 2021 with the goal of applying deep learning approaches to drug discovery. The updated model can also predict protein structures after they’ve been modified. “Basically the new AlphaFold can cope with all of these different things, which is pretty amazing.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Vertigo drug brings hope for rare neuron disorder, Niemann

leisure time

WSS

SAMSHA loosens regulations on methadone treatment centers

Cancer, immunology, HIV research ensnared in fetal tissue politics

The lessons of Aduhelm, an Alzheimer's drug that was not to be

What we need to know about Arena Bioworks

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

U.K. officials, researchers try to ease path for bespoke genetic treatments

entertainment

knowledge

explore

Drug repurposing or repositioning? The language matters

The real point of Kenneth Smith’s execution by nitrogen gas

As demand for Covid shots wanes, Moderna seeks its next success

Medicare drug price negotiation’s day in court

State Dept. review finds Biden bears some blame for Afghanistan failures

Yancopoulos of Regeneron works to expand Dupixent success

After affirmative action ruling, medical educators look to 'holistic review'

Biotech investment managers search for lucrative opportunities

DIEP, the 'gold standard' of breast reconstruction, is under threat

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

focus

Juul spent big to court Black leaders to promote its e

The real point of Kenneth Smith’s execution by nitrogen gas

Asbestos ban is immediate, but health effects will linger for decades

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Do digital therapeutics have a future in medicine?

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

leisure time

Wikipedia

leisure time

Wikipedia